This activity focuses on cannabidiol’s (CBD) role in managing refractory epilepsy. Participants will explore indications, actions, and contraindications pertinent to CBD’s efficacy in managing Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. This discussion also thoroughly reviews CBD’s mechanism of action, adverse event profile, and ongoing research trials involving this drug. Additionally, understanding CBD’s pharmacology helps healthcare professionals to tailor treatment plans to individual patient needs. Enhancing patient care and optimizing outcomes in epilepsy, neuropathic pain, and anxiety disorders requires emphasis on the critical role of the interprofessional healthcare team in overseeing CBD therapy.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/64046
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
Nursing: 2.0 hours
Pharmacy: 2.0 hours - MOC Credit Details: ABS - 2.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 2.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 2.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 2.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Chemical Pathology, Forensic Pathology, Gastroenterology, General Pediatrics, General Surgery, Internal Medicine, Pain Medicine, Pediatric Gastroenterology, Sleep Medicine
Subscribe
Login
0 Comments
Oldest